SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended March 2025 of Rs. 1156.76 millions rose by 25.77% from Rs. 919.77 millions.The Net Profit of the company reported a remarkable increase of 222.49% to Rs. 144.99  millions  from Rs. 44.96 millions in previous same quarter.Operating Profit saw a handsome growth to 266.64 millions from 214.42 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1156.76 919.77 25.77 3701.97 3071.72 20.52 3701.97 3071.72 20.52
Other Income 7.65 5.83 31.22 19.20 18.30 4.92 19.20 18.30 4.92
PBIDT 266.64 214.42 24.35 823.64 684.63 20.30 823.64 684.63 20.30
Interest 24.92 30.57 -18.48 98.78 103.87 -4.90 98.78 103.87 -4.90
PBDT 241.72 112.86 114.18 724.86 509.77 42.19 724.86 509.77 42.19
Depreciation 50.79 50.43 0.71 182.58 195.11 -6.42 182.58 195.11 -6.42
PBT 190.93 62.43 205.83 542.28 314.66 72.34 542.28 314.66 72.34
TAX 45.94 17.47 162.97 143.38 74.83 91.61 143.38 74.83 91.61
Deferred Tax -15.87 1.76 -1001.70 -15.89 -4.37 263.62 -15.89 -4.37 263.62
PAT 144.99 44.96 222.49 398.90 239.83 66.33 398.90 239.83 66.33
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 23.05 23.31 -1.12 22.25 22.29 -0.18 22.25 22.29 -0.18

Kwality Pharma Share Price

1650.00 66.25 (4.18%)
22-Apr-2026 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1659.55
Dr. Reddys Lab 1219.60
Cipla 1233.30
Zydus Lifesciences 930.25
Lupin 2308.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×